Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

PCI Biotech Holding

Less than 1K followers

PCIB

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

PCI Biotech Holding is a biopharmaceutical group, where most of the operations are conducted within the subsidiary PCI Biotech. The group is engaged in the development of therapeutic products based on the proprietary PCI technology. The solutions are intended for use in the treatment of cancer patients. PCI Biotech was originally founded in 2000 as a subsidiary of Photocure and is headquartered in Oslo, Norway.

Read more
Market cap
-
Turnover
-
Revenue
6.74M
EBIT %
-266.47 %
P/E
-
Dividend yield-%
-
All
Press releases
ShowingAll content types
Regulatory press release10/23/2025, 8:35 AM

PCI Biotech update

PCI Biotech Holding
Regulatory press release9/25/2025, 1:36 PM

PCI Biotech update on future operations

PCI Biotech Holding
Regulatory press release8/29/2025, 5:00 AM

PCI Biotech half-year interim 2025 report

PCI Biotech Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release8/26/2025, 2:14 PM

PCI Biotech: Invitation to first half 2025 results presentation and corporate update

PCI Biotech Holding
Regulatory press release8/22/2025, 12:15 PM

PCIB: Flaggemelding

PCI Biotech Holding
Regulatory press release8/22/2025, 12:15 PM

Flaggemelding

PCI Biotech Holding
Regulatory press release8/22/2025, 9:09 AM

PCIB: Flaggemelding

PCI Biotech Holding
Regulatory press release8/22/2025, 9:09 AM

Flaggemelding

PCI Biotech Holding
Regulatory press release8/18/2025, 6:39 PM

PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations

PCI Biotech Holding
Regulatory press release5/22/2025, 9:45 AM

PCI Biotech: Minutes of Annual General Meeting 2025

PCI Biotech Holding
Regulatory press release5/20/2025, 8:08 PM

PCI BIotech: Disclosure of voting rights for Chair of the Board

PCI Biotech Holding
Regulatory press release4/30/2025, 8:00 AM

Notice of Annual General Meeting 2025

PCI Biotech Holding
Regulatory press release4/24/2025, 3:30 PM

PCI Biotech Holding ASA: Annual Report 2024

PCI Biotech Holding
Regulatory press release2/27/2025, 6:00 AM

PCI Biotech full year 2024 interim results

PCI Biotech Holding
Regulatory press release2/25/2025, 7:56 AM

PCI Biotech: Invitation to preliminary full-year 2024 results presentation

PCI Biotech Holding
Regulatory press release1/10/2025, 9:24 AM

PCI Biotech: Employee share option scheme in connection with promotion of new CSO

PCI Biotech Holding
Regulatory press release10/31/2024, 3:33 PM

PCIB: Financial calendar

PCI Biotech Holding
Regulatory press release9/4/2024, 6:57 AM

PCIB: Financial calendar

PCI Biotech Holding
Regulatory press release9/2/2024, 5:53 AM

PCI Biotech: Employee share option scheme

PCI Biotech Holding
Regulatory press release8/28/2024, 5:00 AM

PCI Biotech first half 2024 interim results

PCI Biotech Holding
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.